BioSpace News Archive

Drug Development

Ambrx Biopharma Inc. Announces First Patient Dosed in its Global Phase 2 ACE-Breast-03 Clinical Study of ARX788 for the Treatment of HER2-Positive Metastatic Breast Cancer

Ambrx Biopharma Inc. today announced the first patient has been dosed in its global ACE-Breast-03 Phase 2 clinical study of ARX788 in patients with HER2-positive metastatic breast cancer.

November 4, 2021
·
4 min read
Business

Better Therapeutics Appoints Thiago Licias de Oliveira as Its Chief People Officer

Better Therapeutics, Inc. today announced the appointment of Thiago Licias de Oliveira as its Chief People Officer.

November 4, 2021
·
5 min read
Edesa Biotech Extends COVID-19 Clinical Study to Poland

Edesa Biotech, Inc. today announced that Polish regulators have approved a clinical trial application for the investigational use of the company’s monoclonal antibody candidate, designated EB05

November 4, 2021
·
7 min read
Business

Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results

Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the third quarter of 2021.

November 4, 2021
·
14 min read
Drug Development

Eisai Presents New Data on the Relationship between Clinical, Biomarker and Safety Outcomes from the Lecanemab Phase 2b Study for Early Alzheimer’s disease

Eisai Co., Ltd. (Headquarters: Tokyo , CEO: Haruo Naito , “Eisai”) announced today the presentation of data from the company’s extensive Alzheimer’s disease (AD) pipeline, including six oral presentations that will provide deeper insights into lecanemab’s potential as a treatment for early AD.

November 4, 2021
·
13 min read
Biotech Beach

Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021

Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting ® Digital Experience 2021

November 4, 2021
·
4 min read
Biotech Bay

Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11th

Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11th

November 4, 2021
·
2 min read
Drug Development

Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Patients With Fabry Disease

Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α -Gal A Enzyme Activity in Patients With Fabry Disease

November 4, 2021
·
7 min read
Genetown

GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis

GNS Healthcare and Scipher Medicine ® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis

November 4, 2021
·
4 min read
Biotech Beach

Primmune Therapeutics Receives $8.4 Million in Second Tranche of Series A Financing

Primmune Therapeutics today announced that it has received $8.4 million in a second tranche of the Company’s Series A financing.

November 4, 2021
·
2 min read